Immunolabeling-compatible PEGASOS tissue clearing for high-resolution whole mouse brain imaging

Front Neural Circuits. 2024 Apr 17:18:1345692. doi: 10.3389/fncir.2024.1345692. eCollection 2024.

Abstract

Novel brain clearing methods revolutionize imaging by increasing visualization throughout the brain at high resolution. However, combining the standard tool of immunostaining targets of interest with clearing methods has lagged behind. We integrate whole-mount immunostaining with PEGASOS tissue clearing, referred to as iPEGASOS (immunostaining-compatible PEGASOS), to address the challenge of signal quenching during clearing processes. iPEGASOS effectively enhances molecular-genetically targeted fluorescent signals that are otherwise compromised during conventional clearing procedures. Additionally, we demonstrate the utility of iPEGASOS for visualizing neurochemical markers or viral labels to augment visualization that transgenic mouse lines cannot provide. Our study encompasses three distinct applications, each showcasing the versatility and efficacy of this approach. We employ whole-mount immunostaining to enhance molecular signals in transgenic reporter mouse lines to visualize the whole-brain spatial distribution of specific cellular populations. We also significantly improve the visualization of neural circuit connections by enhancing signals from viral tracers injected into the brain. Last, we show immunostaining without genetic markers to selectively label beta-amyloid deposits in a mouse model of Alzheimer's disease, facilitating the comprehensive whole-brain study of pathological features.

Keywords: Alzheimer’s disease; Light-Sheet; circuit tracing; tissue clearing; whole-mount immunostaining.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Immunohistochemistry
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic*
  • Neuroimaging / methods

Substances

  • Amyloid beta-Peptides

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Grant 1S10MH124715-01 from the National Institutes of Health (NIH): this grant was used to purchase Light-Sheet Microscope from 3i, which was instrumental in conducting the high-resolution imaging required for our study. Grants AG065675 and U01AG076791 from the National Institute on Aging (NIA), part of the NIH: the funding received under the grants were allocated towards the procurement of mouse samples and specialized antibodies essential for our project. TH is funded in part by NIH National Institute of General Medical Sciences grants R35 GM127102.